![Cancer experts outline critical challenges facing the new UK Government](https://cdn.statically.io/img/www.imperial.ac.uk/ImageCropToolT4/imageTool/uploaded-images/newseventsimage_1720624473473_featurenews2012_x1.jpg)
![shadow](https://cdn.statically.io/img/www.imperial.ac.uk/assets/news/img/image_shadow_sidebar.png)
Cancer Care
Cancer experts outline critical challenges facing the new UK Government
Leading doctors and researchers have warned critical challenges in cancer care in the UK need to be urgently addressed by policymakers.
Cancer experts outline critical challenges facing the new UK Government
Leading doctors and researchers have warned critical challenges in cancer care in the UK need to be urgently addressed by policymakers.
Imperial and Crick cancer drug spinout raises £90m to begin clinical development
Myricx Bio is bringing new therapeutic possibilities to the highly promising area of antibody-drug conjugates for treating cancer.
£150,000 study will explore links between breast cancer and breastfeeding
Researchers at Imperial College London have been awarded funding to investigate how breastfeeding lowers the risk of breast cancer.
Cell division decisions and cancer recommendations: News from Imperial
Here’s a batch of fresh news and announcements from across Imperial.
Dotplot wins funding to explore role of breast cancer self-check in primary care
New grants awarded as Dotplot is named New Startup of the Year by the world’s largest cancer research charity, Cancer Research UK.
New prostate cancer screening trial could save thousands of lives
Thousands of patients in the UK could benefit from a new screening trial to detect prostate cancer.
Shape-shifting cancer cell discovery reveals potential skin cancer drug targets
A new technique allows scientists to see cells in 3D, and determine how different genes affect the shapes they adopt.
Superfast physics and a trio of Fellows: News from Imperial
Here’s a batch of fresh news and announcements from across Imperial.
Convergence Science Centre receives £8.9M for clinician research training
Cancer Research UK has awarded Imperial's Convergence Science Centre £8.9 million to train a new generation of clinician scientists.
New synthesis platform allows for rapid cancer drug synthesis and testing
Imperial researchers have developed a new platform for the synthesis, analysis and testing of new compounds which may one day treat cancer